Search results for " Emission"

showing 10 items of 1496 documents

Relevance of functional imaging in dental implantology

2018

Background Despite it is widely used in many medicine fields, the use of functional imaging to examine dental implants has not been reported in the literature. This work aimed to evaluate the relevance of functional medical imaging in oral implantology. Material and methods This single-center observational study was conducted for 6 months at the Toulouse University Hospital, France. All patients who underwent positron emission tomography with 18-fluorodeoxyglucose integrated with X-ray computed tomography (FDG PET/CT) and had dental implants were included. Metabolic activity of the peri-implant tissues was assessed qualitatively and quantitatively jointly by a nuclear physician and a dental…

medicine.medical_specialtyOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryResearch030206 dentistryUniversity hospital:CIENCIAS MÉDICAS [UNESCO]030218 nuclear medicine & medical imagingFunctional imaging03 medical and health sciences0302 clinical medicineDental implantologyPositron emission tomographyUNESCO::CIENCIAS MÉDICASMedical imagingHypermetabolismMedicinemedia_common.cataloged_instanceRadiologybusinessImaging processingGeneral DentistryDental surgeonmedia_common
researchProduct

Molecular imaging of gastroenteropancreatic neuroendocrine tumors.

2010

Somatostatin-receptor scintigraphy has become an obligatory molecular imaging method in the management of patients with neuroendocrine tumors when metastatic disease is suspected. Using positron emission tomography and new somatostatin analogues, sensitivity of somatostatin receptor imaging has further increased. With a combination of morphologic imaging methods, such as hybrid imaging by PET/CT, this method represents the method of choice in many centers and efforts are under way to translate somatostatin receptor imaging onto a cellular level by endoscopic confocal microscopy. Other clinically relevant functional pathways in neuroendocrine tumors that are accessible by PET imaging are glu…

medicine.medical_specialtyPathologyNeuroendocrine tumorsScintigraphylaw.inventionConfocal microscopylawmedicineHumansReceptors SomatostatinGastrointestinal NeoplasmsMicroscopy Confocalmedicine.diagnostic_testbusiness.industrySomatostatin receptorGastroenterologyPet imagingmedicine.diseaseCarcinoma NeuroendocrineMolecular ImagingPancreatic NeoplasmsNeuroendocrine TumorsSomatostatinPositron emission tomographyPositron-Emission TomographyRadiologyMolecular imagingRadiopharmaceuticalsbusinessGastroenterology clinics of North America
researchProduct

6-18F-Fluoro-l-Dihydroxyphenylalanine Positron Emission Tomography Is Superior to123I-Metaiodobenzyl-Guanidine Scintigraphy in the Detection of Extra…

2010

Context: Pheochromocytomas (PHEOs) and paragangliomas (PGLs) may be better detected by 18F-fluorodihydroxyphenylalanine-positron emission tomography (FDOPA-PET) than 123I-metaiodobenzyl-guanidine (123-I-MIBG) scintigraphy. Objective: The objective of the study was to correlate functional imaging results with immunohistochemical, molecular-genetic, and biochemical findings. Design and Setting: Thirty consecutive patients with suspected PHEO/PGL presenting at a tertiary referral centre were investigated in a prospective study. Patients: Twenty-five patients had confirmed PHEO/PGL. Thirteen of 25 patients had a hereditary PHEO/PGL syndrome (two multiple endocrine neoplasia II, six succinate de…

medicine.medical_specialtyPathologymedicine.diagnostic_testbusiness.industryEndocrinology Diabetes and MetabolismBiochemistry (medical)Clinical BiochemistryMagnetic resonance imagingContext (language use)medicine.diseaseScintigraphyBiochemistryDihydroxyphenylalaninePheochromocytomachemistry.chemical_compoundEndocrinologyEndocrinologychemistryPositron emission tomographyParagangliomaInternal medicinemedicineMultiple endocrine neoplasiabusinessThe Journal of Clinical Endocrinology & Metabolism
researchProduct

Systematic review of the association between particulate matter exposure and autism spectrum disorders

2017

Particulate matter (PM) as an environmental pollutant is suspected to be associated with autism spectrum disorders. The aim of the present study was to review the epidemiological literature currently available on the relation between PM exposure and diagnosis of ASD. The PubMed database was searched from November 2015 up to January 2016 by one of the authors. We included observational studies (cohort and case control studies) published in English carried out in children within the last 10 years, measuring PM exposure and health outcomes related to ASD. 13 studies met the inclusion criteria. Four of the studies found no association between PM exposure and ASD. The other 8 studies show positi…

medicine.medical_specialtyPediatricsAutism Spectrum Disorder010501 environmental sciences01 natural sciencesBiochemistry03 medical and health sciences0302 clinical medicinePregnancyStatistical significanceEnvironmental healthEpidemiologymedicineHumansVehicle Emissions0105 earth and related environmental sciencesGeneral Environmental Sciencebusiness.industryPublic healthConfoundingmedicine.diseasePrenatal Exposure Delayed EffectsCohortAutismFemaleParticulate MatterObservational studybusiness030217 neurology & neurosurgeryCohort study
researchProduct

Neurosurgery of Malignant Brain Tumors

1987

To Virchow 167 belongs the credit of identifying as tumors, tissue changes already described in the brain, and at the same time to have published an account of the characteristics of the gliomas and the first classification of the various types. It was only the knowledge of the neoplastic nature of the gliomas 127 which made possible surgical action with the aim of extirpation (Fig. 1), when at the end of the 19th century the stormy development of surgery in other parts of the body was being practised successfully 162. The first reports about the removal of an intracerebral space-occupying lesion came from Wernicke and Hahn (1881)183 and also from Bennett and Godley (1884)16. In both cases …

medicine.medical_specialtyPilocytic astrocytomamedicine.diagnostic_testbusiness.industrymedicine.diseaseFourth ventricleLesionPositron emission tomographyGliomamedicineNeurosurgeryRadiologymedicine.symptombusinessAbscessIntracranial pressure
researchProduct

Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases

2018

The risk of cardiovascular (CV) events and mortality is significantly higher in patients with systemic rheumatic diseases than in the general population. Although CV involvement in such patients is highly heterogeneous and may affect various structures of the heart, it can now be diagnosed earlier and promptly treated. Various types of assessments are employed for the evaluation of CV risk such as transthoracic or transesophageal echocardiography, magnetic resonance imaging (MRI), and computed tomography (CT) to investigate valve abnormalities, pericardial disease, and ventricular wall motion defects. The diameter of coronary arteries can be assessed using invasive quantitative coronarograp…

medicine.medical_specialtyPopulationSpeckle tracking echocardiographyReview030204 cardiovascular system & hematologyendothelial dysfunction03 medical and health sciences0302 clinical medicinemedicine.arteryInternal medicineIntravascular ultrasoundmedicinesystemic rheumatic diseasesBrachial arteryeducationatherosclerosis; computed tomography; coronary artery diseases; endothelial dysfunction; plasma asymmetric dimethylarginine; systemic rheumatic diseases030203 arthritis & rheumatologyeducation.field_of_studylcsh:R5-920medicine.diagnostic_testbusiness.industryCoronary flow reserveMagnetic resonance imagingcomputed tomographyGeneral Medicineplasma asymmetric dimethylarginineCoronary arteriescoronary artery diseasesmedicine.anatomical_structurePositron emission tomographyCardiologyMedicineatherosclerosisbusinesslcsh:Medicine (General)Frontiers in Medicine
researchProduct

The role of PET radiomic features in prostate cancer: a systematic review

2021

Aim: This systematic review aims to present the available evidence on the use of radiomic features (RFs) extracted from PET imaging in patients with prostate cancer (PCa). Materials and methods: A comprehensive literature search of studies on the utility of PET-derived RFs in patients with PCa was performed in the PubMed/MEDLINE database through February 24th, 2021 using the following search string: [“positron-emission tomography” (MeSh terms) OR “positron emission tomography computed tomography” (MeSh terms) OR “positron-emission tomography” (all fields) OR “positron emission tomography computed tomography” (all fields) OR “PET” (all fields)] AND [“radiomics” (all fields) OR “radiomic” (al…

medicine.medical_specialtyPositron emission tomographymedicine.medical_treatmentRadiogenomics030218 nuclear medicine & medical imaging03 medical and health sciencesProstate cancer0302 clinical medicineProstateMachine learningCarcinomamedicineRadiology Nuclear Medicine and imagingLymph nodeProstate cancerRadiomicsmedicine.diagnostic_testbusiness.industryInterventional radiologyDeep learningmedicine.diseaseRadiation therapymedicine.anatomical_structure030220 oncology & carcinogenesisRadiologyTomographybusiness
researchProduct

Hepatic mesenchymal hamartoma in a preterm newborn: demonstration by low-dose multidetector CT.

2007

Primary liver tumours are very rare in the neonatal period. Differential diagnoses include haemangioendothelioma, malignant hepatoblastoma and mesenchymal hamartoma. Due to non-specific clinical symptoms and indecisive imaging findings, correct diagnosis may be difficult to establish. We report a female preterm newborn who was delivered at 33 weeks of gestation and in whom ultrasonography (US) revealed a large cystic intraabdominal tumour of unknown origin. For further evaluation, contrast-enhanced multidetector computed tomography (CT) was performed on the 4th day of life using a low-dose protocol (80 kVp, 50 mAs, collimation 0.75 mm, total effective dose 3.6 mSv). Based on CT findings, di…

medicine.medical_specialtyPregnancyHepatoblastomabusiness.industryHamartomaLiver DiseasesMesenchymal stem cellLiver NeoplasmsInfant NewbornGeneral MedicineMultidetector ctmedicine.diseaseEffective dose (radiation)MesodermPediatrics Perinatology and Child HealthmedicineGestationHamartomaHumansFemaleRadiologyMedical diagnosisbusinessInfant PrematureTomography Emission-ComputedActa paediatrica (Oslo, Norway : 1992)
researchProduct

Mechanism of New Antipsychotic Medications

2003

Antagonism of D 2 -like dopamine receptors is the putative mechanism underlying the antipsychotic efficacy of psychotropic drugs. Positron emission tomographic studies suggest that the antipsychotic effect of dopamine receptor antagonists occurs within a therapeutic window between 60% and 80%(striatal) D 2 receptor occupancy. The incidence of extrapyramidal side effects increases above the 80% threshold. However, the novel atypical antipsychotic drug, aripiprazole, occupies up to 95% of striatal D 2 -like dopamine receptors at clinical doses, and the incidence of extrapyramidal side effects with aripiprazole is no higher than with placebo. The most likely explanation for this finding is ari…

medicine.medical_specialtyPsychosismedicine.drug_classmedicine.medical_treatmentAripiprazoleAtypical antipsychoticQuinolonesPharmacologyPartial agonistPiperazinesBasal Ganglia DiseasesArts and Humanities (miscellaneous)Dopamine receptor D2Internal medicinemedicineHumansAntipsychoticDose-Response Relationship DrugReceptors Dopamine D2Putamenmedicine.diseaseCorpus StriatumProlactinDopamine D2 Receptor AntagonistsPsychiatry and Mental healthEndocrinologyMechanism of actionDopamine receptorSchizophreniaAripiprazolemedicine.symptomPsychologyAntipsychotic AgentsTomography Emission-Computedmedicine.drugArchives of General Psychiatry
researchProduct

D2-receptor imaging with [123I]IBZM and Single Photon Emission Tomography in psychiatry: a survey of current status

1995

D2-dopamine receptors can be visualized in the human brain in vivo by Single Photon Emission Tomography (SPECT) and the radiolabeled benzamide [123I]IBZM. The present paper reviews the current status of this type of functional brain imaging with respect to basic methodological aspects, data analysis and quantification. The results from published clinical studies in different psychiatric patient populations and normal controls with [123I]IBZM are reviewed. [123I]IBZM-SPECT is a powerful tool for the investigation of D2-dopamine receptor status in psychiatric disorders, different types of drug treatment as well as therapeutic and side effects of pharmacologic agents. However, there still is a…

medicine.medical_specialtyReceptor StatusPyrrolidinesNeurologyContrast MediaDrug treatmentDopamine receptor D2Image Processing Computer-AssistedmedicineSingle Photon Emission TomographyHumansPsychiatryBiological PsychiatryBrain ChemistryTomography Emission-Computed Single-Photonmedicine.diagnostic_testReceptors Dopamine D2business.industryBrainHuman brainPsychiatry and Mental healthmedicine.anatomical_structureNeurology123i ibzmPositron emission tomographyBenzamidesDopamine AntagonistsNeurology (clinical)Nuclear medicinebusinessPsychologyJournal of Neural Transmission
researchProduct